Hospitals purchased Impella 2.5 through the quarter, bringing the full total to 521 customer sites. Gross margin price for the fourth quarter of fiscal 2011 was 80 percent, compared to 73 percent in the fourth quarter of fiscal 2010. Non-Impella revenue was $6.1 million for the fourth quarter of fiscal 2011, 2 percent less than $6.2 million in the fourth quarter of fiscal 2010. Non-GAAP net income, which is described later in this press release for the 4th quarter of fiscal 2011, was $0.6 million, or $0.01 per diluted talk about versus a non-GAAP net lack of $4.1 million or $0.11 per diluted and simple share, in the fourth quarter of fiscal 2010. The full 2011 fiscal 12 months non-GAAP net reduction was $2.1 million or $0.06 per share in comparison to a non-GAAP net lack of $13.5 million or $0.37 per share for fiscal 2010.The most recent national 5-calendar year survival for distant disease for 25 – to 39-year-old ladies is only 31 % according to SEER data, compared with a 5-calendar year survival rate of 87 % for women with locoregional breast tumor,’ the authors write.. Advanced prostate cancer can be treated successfully with intermittent chemotherapy Advanced prostate cancer could be treated successfully with intermittent chemotherapy, according to a study conducted by Oregon Wellness & Research University Cancer Institute scientists.